M Sea Pharmaceuticals Private Limited is India based ISO 9001-2015, GLP, WHO GMP certified pharmaceutical company engaged with pharma manufacturing services. M Sea Pharma is one of the leading pharmaceutical manufacturing company in India, manufacturers of Pharmaceutical formulations and known in the pharmaceutical and healthcare industry, due to our ability to manufacture and supply a diverse and qualitative range of products in TABLETS, CAPSULES, SYRUPS & DRY SYRUPS forms.

2010 was the year in which M Sea Pharma was founded. The manufacturing facilities are at Paonta Sahib (A major industrial towns of Himachal Pradesh in India), an easily accessible area that is around 120 Kilometers away from Chandigarh.

The beginnings were modest. It had a small factory and the worker-employee strength of the company was 15 which today has grown to more than 100 and increasing with expanding of the company.

Today, we have state of the art manufacturing facility with plant as per WHO-GMP norms. M Sea Pharma is a professionally managed company engaged in manufacturing of "Pharmaceutical & Healthcare" based products, started its operations in 2011 to provide wide range of high quality and cost effective Pharmaceutical products.

M Sea Pharma is a professionally managed company engaged in manufacturing of "Pharmaceutical & Healthcare" based products, started its operations in 2011 to provide wide range of high quality and cost effective Pharmaceutical products. The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies. Manufacturing of quality pharmaceutical formulations affordable to the Indian masses and having global quality is our motto.

  • The M Sea Pharma has been registered with Registrar of Companies on April 01, 2015.
  • The FDA Himachal Pradesh issued the Manufacturing License to M Sea Pharma on October 2010, & further renewal on 2015.
  • Company approved the proposed plan for Oral liquid Preparation manufacturing section as per revised schedule "M" on June 2017.